High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$87K
$87,646
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
KALV
S
KalVista Pharmaceuticals, Inc.
Piekos Brian
• CFO
Sell to CoverΔOwn -11.4%
2026-02-23
$27,507
|
||||||
| KALV |
KalVista Pharmaceuticals, Inc.
|
CFO
Sell to CoverΔOwn -11.4%
|
2026-02-23 | $27,507 | S | Form 4 |
|
KALV
S
KalVista Pharmaceuticals, Inc.
Piekos Brian
• CFO
Sell to CoverΔOwn -29.8%
2025-11-24
$60,139
|
||||||
| KALV |
KalVista Pharmaceuticals, Inc.
|
CFO
Sell to CoverΔOwn -29.8%
|
2025-11-24 | $60,139 | S | Form 4 |